Latest Breaking News On - Anna protopapas - Page 1 : comparemela.com

Mersana Therapeutics, Inc (NASDAQ:MRSN) Receives Average Recommendation of Moderate Buy from Analysts

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven analysts that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 […]

Nova scotiaAnna protopapasRobertw bairdBrian deschuytnerJpmorgan chase coSecurities exchange commissionBlackrock incJanssen biotech incMersana therapeutics incAsana biosciencesSwiss national bankMerck kgaaHermes incMerck kgaMersana therapeuticsGet free report

Mersana Therapeutics (NASDAQ:MRSN) Upgraded at JPMorgan Chase & Co

Mersana Therapeutics (NASDAQ:MRSN) Upgraded at JPMorgan Chase & Co
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdBrian deschuytnerAnna protopapasMerck kgaaMerck kgaJanssen biotech incJpmorgan chase coVictory capital management incAsana biosciencesMersana therapeutics incMersana therapeutics company profileMersana therapeuticsFree reportTruist financialModerate buy

Truist Financial Upgrades Mersana Therapeutics (NASDAQ:MRSN) to Buy

Mersana Therapeutics (NASDAQ:MRSN – Get Free Report) was upgraded by equities researchers at Truist Financial from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, Benzinga reports. The firm presently has a $9.00 price objective on the stock. Truist Financial’s price target would indicate a potential upside of 85.57% […]

Hong kongRobertw bairdAnna protopapasBrian deschuytnerMerck kgaSphera funds managementY intercept hong kong ltdJanssen biotech incMersana therapeutics incAsana biosciencesLife insurance coSecurities exchange commissionMerck kgaaMersana therapeuticsGet free reportTruist financial

Mersana Therapeutics (NASDAQ:MRSN) Issues Quarterly Earnings Results

Mersana Therapeutics (NASDAQ:MRSN) Issues Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong kongBrian deschuytnerAnna protopapasMersana therapeutics incMerck kgaaRoyal bankSei investments coSecurities exchange commissionHong kong ltdMerck kgaTower research capitalPrincipal financial group incJanssen biotech incAsana biosciencesMersana therapeuticsGet free report

Nuvalent (NASDAQ:NUVL) Issues Earnings Results, Misses Estimates By $0 02 EPS

Nuvalent (NASDAQ:NUVL) Issues Earnings Results, Misses Estimates By $0 02 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Anna protopapasAlexandra balcomRobertw bairdLeerink partnrsTower research capitalNuvalent incNuvalent company profileRoyal bankGet free reportStock downDirector anna protopapasResearch capitalAmalgamated bankNuvalent daily